Management ChangeApr 14, 2026, 08:21 AM
Harmony Biosciences Appoints Glenn Reicin as New CFO
AI Summary
Harmony Biosciences Holdings, Inc. announced a change in its Chief Financial Officer position. Sandip Kapadia stepped down as CFO, effective April 14, 2026, to pursue other career opportunities. Concurrently, Glenn Reicin was appointed as the new Chief Financial Officer, effective the same day. Mr. Reicin brings extensive experience, having previously served as CFO at Eccogene, Inc. and Alladapt Immunotherapeutics, Inc.
Key Highlights
- Sandip Kapadia resigned as CFO, effective April 14, 2026.
- Glenn Reicin appointed as new CFO, effective April 14, 2026.
- Mr. Reicin, age 61, previously served as CFO at Eccogene, Inc.
- He also held CFO and COO roles at Alladapt Immunotherapeutics, Inc.
Price Impact
More from HRMY